Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014, 5:14

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Osiris Therapeutics Inc. (OSIR) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on OSIR
Small biopharma Osiris jumps after reporting an unexpected profit 11:23 a.m. March 5, 2014 - Russ Britt
Earnings, deals aid medical supplier, biopharmas on mixed market day 10:32 a.m. Oct. 11, 2013 - Russ Britt
Six stocks with continuing upside 1:50 p.m. Aug. 14, 2013 - The Trading Deck
Osiris keeps losses down, investors reward shares 7:34 p.m. March 6, 2013 - Russ Britt
Osiris Therapeutics down 5% in premarket trades 7:25 a.m. July 3, 2012 - Steve Gelsi
Thursday’s biggest gaining and declining stocks 3:56 p.m. June 21, 2012 - MarketWatch
Monday’s biggest gaining and declining stocks 3:24 p.m. June 18, 2012 - MarketWatch
Osiris gains on New Zealand regulatory approval 11:57 a.m. June 18, 2012 - Val Brickates Kennedy
Osiris: Gov't OKs pass-through status for Grafix 5:44 p.m. May 29, 2012 - MarketWatch.com
Osiris shares rally for second straight session 1:10 p.m. May 21, 2012 - Val Brickates Kennedy
Stocks to watch Friday: Osiris, Autodesk, Marvell 5:49 a.m. May 18, 2012 - MarketWatch
Osiris stem-cell therapy wins Canadian approval 4:43 p.m. May 17, 2012 - Val Brickates Kennedy
Osiris up 14% after Canada OKs stem-cell treatment 4:33 p.m. May 17, 2012 - Carla Mozee
Court upholds stem-cell research funding: reports 10:46 a.m. July 27, 2011 - Val Brickates Kennedy
Are stem-cell stocks a good buy? 2:06 p.m. July 13, 2011 - Val Brickates Kennedy
Stem-cell stocks rise on artificial-trachea report 1:57 p.m. July 8, 2011 - Val Brickates Kennedy
Radiation drug makers lose some ground 11:31 a.m. March 16, 2011 - Russ Britt
Appeals court blocks stem-cell funding ban: AP 2:51 p.m. Sept. 9, 2010 - Val Brickates Kennedy
Stem-cell stocks regain ground 3:13 p.m. Aug. 26, 2010 - Val Brickates Kennedy
Drug stocks trend higher in afternoon action 11:59 a.m. June 24, 2009 - Val Brickates Kennedy


Other News on OSIR
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics, Inc. (OSIR): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Nov. 12, 2014 - Zacks.com
Osiris Therapeutics Beats on Q3 Earnings & Revenues - Analyst Blog 9:00 a.m. Nov. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 10:35 a.m. Nov. 10, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics' (OSIR) CEO Lode Debrabandere on Q3 2014 Results - Earnings Call Transcript 12:00 p.m. Nov. 7, 2014 - Seeking Alpha
Osiris Therapeutics (OSIR) Q3 2014 Results - Earnings Call Webcast 8:55 a.m. Nov. 7, 2014 - Seeking Alpha
Japan Gives A Hug To The Cell Therapy Industry: R. Lee Buckler 7:21 a.m. Oct. 24, 2014 - Seeking Alpha
Avita Medical: A Comprehensive Look At An Unknown Company With A Transcendent Technology 12:35 p.m. Oct. 7, 2014 - Seeking Alpha
Update: Osiris Therapeutics Earnings 7:55 a.m. Aug. 15, 2014 - Seeking Alpha
Osiris Falls despite Narrower Q2 Loss and Higher Revenues - Analyst Blog 10:50 a.m. Aug. 11, 2014 - Zacks.com
10-Q: OSIRIS THERAPEUTICS, INC. 5:11 a.m. Aug. 11, 2014 - Edgar Online - (EDG = 10Q, 10K)
Osiris Therapeutics (OSIR) Q1 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market 3:50 p.m. July 29, 2014 - GuruFocus.com
Arena Pharmaceuticals-Eisai Boost Obesity Drug Sales Force - Analyst Blog 3:45 p.m. July 11, 2014 - Zacks.com
Osiris Therapeutics' Survival In Doubt After Losing 'Pass-Through' Status In 2015 10:56 a.m. July 11, 2014 - Seeking Alpha
Lexicon (LXRX) Jumps: Stock Moves 7.6% Higher - Tale of the Tape 8:46 a.m. July 10, 2014 - Zacks.com
BIND Therapeutics (BIND) in Focus: Stock Tumbles 10.0% - Tale of the Tape 7:44 a.m. July 7, 2014 - Zacks.com
Merge Healthcare: Updated Research Report - Analyst Blog 1:55 p.m. June 20, 2014 - Zacks.com
Illumina: Updated Research Report - Analyst Blog 1:30 p.m. June 20, 2014 - Zacks.com
Geron Gains as FDA Lifts Partial Hold on Imetelstat Study - Analyst Blog 12:10 p.m. June 13, 2014 - Zacks.com

Press Releases on OSIR
Osiris Therapeutics to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum 8:04 a.m. Nov. 17, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Third Quarter 2014 Financial Results: Revenue up 29% and Company Turned Profitable 8:02 a.m. Nov. 7, 2014 - BusinessWire - BZX
Reckitt Benckiser Pharmaceuticals Inc. Announces Appointment of Chief Financial Officer 8:00 a.m. Nov. 4, 2014 - PR Newswire - PRF
Osiris and Arthrex announce an exclusive partnership for the commercialization and development of Cartiform® 7:01 a.m. Oct. 17, 2014 - BusinessWire - BZX
Osiris to present three studies on benefits of cryopreserved placental membranes for chronic wounds 7:02 a.m. Oct. 16, 2014 - BusinessWire - BZX
Analysis of the Global Stem Cell Market 2:14 p.m. Oct. 13, 2014 - PR Newswire - PRF
Osiris Therapeutics Announces Third Quarter 2014 Financial Results Conference Call 10:58 a.m. Oct. 13, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa 7:01 a.m. Sept. 25, 2014 - BusinessWire - BZX
Grafix® Featured in Plenary Session Oral Presentation at the Joint Annual Meeting of the Eastern and New England Vascular Societies 3:16 p.m. Sept. 15, 2014 - BusinessWire - BZX
Grafix® Randomized Controlled Clinical Trial Recognized as High Quality DFU Trial in Recent Wounds Supplement 8:02 a.m. Sept. 11, 2014 - BusinessWire - BZX
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Osiris Therapeutics, Inc. -- OSIR 9:37 a.m. Aug. 14, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results: Revenue Up 32% Over Previous Quarter 7:04 a.m. Aug. 7, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Available Electronically in Peer-Reviewed Journal 3:00 p.m. July 22, 2014 - BusinessWire - BZX
Osiris Therapeutics Announces Second Quarter 2014 Financial Results Conference Call 3:00 p.m. July 14, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the 9th Annual JMP Securities Healthcare Conference 7:00 a.m. June 20, 2014 - BusinessWire - BZX
Grafix® Manuscript from Osiris’ Multi-center, Randomized, Controlled Clinical Trial Accepted in Peer-Reviewed Journal 7:02 a.m. June 19, 2014 - BusinessWire - BZX
Osiris Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 7:01 a.m. May 30, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 6:00 a.m. May 19, 2014 - PR Newswire - PRF
MediPoint: Bone Grafts and Substitutes - Global Analysis and Market Forecasts 11:33 a.m. May 14, 2014 - PR Newswire - PRF
Osiris Reports First Quarter 2014 Results: Revenue Up 25% and Gross Margin Improved from 73% to 78% 3:01 p.m. May 12, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 89

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Palm Beach Loan Company Tests Luxury Lending Demand

Updated Category News Views 57

Jewelry in a safe is dead capital until somebody lends against it. That plain fact sits behind Luxury Asset Capital's latest move: the launch of Palm Beach Loan Company, a South Florida brand aimed at wealthy owners of watches, diamonds, art, handbags, gold, collectibles, and other high-value possessions. The company is not asking clients to sell the stuff they spent...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 71

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Universal Haptics Protocol May Cut Integration Friction

Updated Category News Views 291

A controller rumbling at the wrong moment is a small annoyance, but the plumbing behind that rumble has been a stubborn mess for years. The Haptics Industry Forum's Universal Haptics Protocol 1.0, announced November 17, 2026, is an attempt to clean up that mess with a shared language between software and touch-feedback hardware. This is not the sort of release that sends...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 93

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Triple Crossing Tests a Tough Inland Marine Market

Updated Category News Views 105

Inland marine is where tidy insurance appetites go to get bent out of shape. A contractor’s rented machine, cargo moving between points, a half-finished building, or equipment that is neither parked forever nor easy to classify can turn a standard quote into a week of broker phone calls. Triple Crossing Specialty is stepping directly into that mess, launching a new...

Continue Reading
Midea's Cooling Systems Take Center Stage at DCW ME

Updated Category News Views 64

AI Surge Demands Cooler Solutions Alright, who'd guess that data centers would feel the heat—literally—like a welder's furnace in Abu Dhabi? As AI demand burns hotter across the Middle East, data centers are sweating it out against 50°C-plus temperatures. We're talking about some serious pressure on traditional cooling methods that just can’t cut it anymore....

Continue Reading
Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 147

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
DEFSEC Tackles Nasdaq Bid Price Hurdle with Share Move

Updated Category News Views 25

Navigating Bid Price Deficiency Issues Well, it seems DEFSEC Technologies Inc. found themselves in a tricky spot last week. A nasty gram from Nasdaq’s Listing Qualifications Department pointing out that DEFSEC's shares had dipped below that $1.00 per share requirement for too long—a full 30 business days. Now, don't panic just yet. This isn't about the shares getting...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading

Top 5 Most Recently Viewed Articles

Surge in Gold Prices Reflects Political and Economic Tensions

Updated Category News Views 283

Gold Prices Reach New Heights Amid Political Turmoil Gold prices have reached unprecedented levels recently, reflecting a surge in safe-haven demand driven by rising political uncertainties in key regions like the U.S. and Japan. As concerns about potential economic instability grow, this precious metal has emerged as a popular choice for investors looking to protect...

Continue Reading
BlackSky Secures Navy Contract to Enhance Satellite Imaging

Updated Category News Views 222

Alright, here’s the scoop: BlackSky Technology Inc. just bagged a major contract with the U.S. Navy, and it’s all about beefing up their Gen-3 imaging satellites. Now, why does this matter? This initiative is a piece of the broader Project Overmatch—a military strategy designed to supercharge the Joint All Domain Command and Control (JADC2) mission. What’s at...

Continue Reading
Discover the Innovative FINGER GRIP for Enhanced Sports Performance

Updated Category News Views 217

Enhancing Sports with the Innovative FINGER GRIP In the dynamic world of sports, having the right equipment can make all the difference. An inventive mind from Pittsburgh has introduced an innovative product, the FINGER GRIP, aimed at elevating performance in games like pickleball and tennis. This new grip is revolutionizing how athletes interact with their paddles and...

Continue Reading
Updated Voting Shares of AB Volvo: Significant Changes

Updated Category News Views 215

Changes in AB Volvo's Voting Shares AB Volvo has recently undergone an important transformation affecting its voting shares. The conversion of 175,000 Series A shares into Series B shares is a key development for the company. This conversion stems from a provision accepted at the 2011 Annual General Meeting, allowing Series A shareholders to switch their shares to Series...

Continue Reading
Warner Bros. Discovery's Q4: Strong Revenue Growth & Future Plans

Updated Category News Views 324

Warner Bros. Discovery Reports Impressive Q4 Results In a recent financial assessment, Warner Bros. Discovery, Inc (NASDAQ: WBD) unveiled its latest quarterly performance, showcasing a fiscal fourth-quarter revenue of $10.03 billion. Although this represented a slight 1% ex-FX decline compared to the previous year, it was just shy of analysts' expectations of $10.19...

Continue Reading